For patients awaiting stoma reversal surgery, there is good news.

Published Date: 26 Apr 2023

According to new research, patients can rest assured that postponing stoma reversal surgery has no impact on long-term results.

Read Full News

Latest News

Early Predictors of Crohn’s Disease Recurrence Identified

Guidelines recommend endoscopy at 6-12 months post-resection, but new evidence suggests ultrasound and fecal testing at 3 months can predict higher risk earlier.

How Gut Bugs Use the Vagus Nerve as a Backdoor to the Brain

New research suggests a high-fat diet can turn the vagus nerve into a microbial highway, allowing gut bacteria to breach the brain.

Extent of Family History Not Tied to Pancreatic Cancer Risk

The number of family relatives, first-degree or not, who have pancreatic cancer does not appear to affect the risk for intermediate lesions.

Two Studies Contrast Therapies for Liver Disease

One study compared cost-effectiveness between treatments, the other mortality rates and other long-term outcomes for GLP1-s versus SGLT2 inhibitors.

Mirum's Rare Liver Disease Drug Meets Main Goal in Mid-stage Study

Mirum Pharmaceuticals said on Monday its experimental drug, volixibat, met the main ⁠goal of a mid-stage study by reducing severe itching or pruritus in patients with ⁠a...

Trump Administration Appeals Judge's Order Upending Kennedy's Vaccine Policies

The Trump administration on Wednesday appealed a federal judge's ruling blocking key elements of Health Secretary Robert F. Kennedy Jr.'s push to reshape U.S. vaccine...

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Latest News

Guidelines recommend endoscopy at 6-12 months post-resection, but new evidence suggests ultrasound and fecal testing at 3 months can predict higher risk earlier.

New research suggests a high-fat diet can turn the vagus nerve into a microbial highway, allowing gut bacteria to breach the brain.

The number of family relatives, first-degree or not, who have pancreatic cancer does not appear to affect the risk for intermediate lesions.

One study compared cost-effectiveness between treatments, the other mortality rates and other long-term outcomes for GLP1-s versus SGLT2 inhibitors.

Mirum Pharmaceuticals said on Monday its experimental drug, volixibat, met the main ⁠goal of a mid-stage study by reducing severe itching or pruritus in patients with ⁠a...

The Trump administration on Wednesday appealed a federal judge's ruling blocking key elements of Health Secretary Robert F. Kennedy Jr.'s push to reshape U.S. vaccine...

News All Time

Preservatives and Cancer: What's the Real Risk?

Patients are increasingly asking about "chemicals" in food. What can clinicians tell them about preservatives and cancer risk?

Drug-Resistant Shigella Surges in Adult Men

Most previous US outbreaks involved children infected with drug-susceptible strains.

Sexual Dysfunction in Digestive Diseases Often Missed

Digestive diseases and treatments may affect sexual function; however, clinicians address these concerns in a minority of patients despite unmet needs.

Celiac Disease Symptoms Vary by Race and Ethnicity

Race- and ethnicity-based disparities in symptom presentation and comorbidity patterns exist among patients with celiac disease.

Locally Advanced Rectal Cancer Responds to HER2 Therapy

Six of eight patients (75%) with HER2-positive rectal adenocarcinoma responded to trastuzumab and tucatinib plus chemotherapy, including four clinical complete responses.

Vitamin C’s Potential Use in Cancer Is Getting a Second Look

Decades after early trials seemed to close the book on vitamin C as a cancer treatment, a member of a group of determined researchers is receiving the therapy himself.

Education Gap Tied to Higher Risk for Young-Onset CRC Death

Researchers analyze trends in colorectal cancer mortality among adults aged 25-49 years in a study spanning about three decades.

Aspirin Unlikely to Cut Colorectal Cancer Incidence

A Cochrane Review finds aspirin likely results in little to no difference in colorectal cancer incidence at a follow-up of 5 years to less than 15 years.

Tumor Genomic Testing: Too Little, Too Late

Tumor genomic testing is critical to informed treatment decisions, but researchers find that it’s used in too few patients and often too late.

High-Impact Exercise Linked to Anal Incontinence in Women

High-impact sports may increase the risk for anal incontinence, especially among women, with many cases underdiagnosed because of stigma and low awareness.

Spyre's Inflammatory Bowel Drug Shown to Reduce Disease Activity in Mid-stage Study

Spyre Therapeutics said on Monday its experimental drug showed a significant reduction in disease activity when ⁠tested in patients with ulcerative colitis in a mid-stage...

Age and Visceral Fat May Trend Together: What to Know

Why fat that surrounds organs is more dangerous continues to be studied.

Vaccination Protects Young Men From HPV-Related Cancers

HPV-related cancers — including anal, penile, and oropharyngeal — are rare in people younger than 50, but new research suggests vaccinated boys could see cancer protection in their teens and 20s.

The Intersection Between Gut and Spine Health

Emerging research is showing more and more connection between the two.

IBD Flare Prediction Improved by Psychosocial Data

Predictive models that combine patient-reported psychosocial measures with clinical data perform well in forecasting flares in patients with inflammatory bowel disease.

Sacral Fracture Risk After Short-Course RT for Rectal Cancer

A recent retrospective analysis assesses the incidence and risk factors for sacral fractures among patients receiving short-course radiation therapy for rectal cancer.

Recommended News For You

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

New Standard of Care in High-Risk Acute Promyelocytic Leukemia?

Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma

DNA origami offers more accurate imaging in the fight against pancreatic cancer

Recommended Articles For You

HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways 

The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape 

Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice 

Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.

2.

FDA approves rivanetin as the first-line treatment for lung cancer.

3.

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

4.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

5.

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

1.

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential

2.

An Overview Of Daunorubicin: What Is It Used For And How Does It Work?

3.

Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment

4.

Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians

5.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

2.

Understanding the causes of anemia in adults beyond nutritional deficiencies

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

4.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot